Cargando…
Cancer research in the era of immunogenomics
The most meaningful advancement in cancer treatment in recent years has been the emergence of immunotherapy. Checkpoint inhibitor blockade and adoptive T cell therapy have shown remarkable clinical effects in a wide range of tumour types. Despite these advances, many tumours do not respond to these...
Autores principales: | Wolf, Yochai, Samuels, Yardena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307593/ https://www.ncbi.nlm.nih.gov/pubmed/30622743 http://dx.doi.org/10.1136/esmoopen-2018-000475 |
Ejemplares similares
-
Intratumor Heterogeneity and Antitumor Immunity Shape One Another Bidirectionally
por: Wolf, Yochai, et al.
Publicado: (2022) -
Neoantigens in cancer immunotherapy: quantity vs. quality
por: Wolf, Yochai, et al.
Publicado: (2023) -
Immunogenomics: Molecular hide and seek
por: Miretti, Marcos M, et al.
Publicado: (2006) -
Immunogenomic Classification of Colorectal Cancer and Therapeutic Implications
por: Roelands, Jessica, et al.
Publicado: (2017) -
Classification of gastric cancers based on immunogenomic profiling
por: Liu, Zhixian, et al.
Publicado: (2020)